All TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Stable. As always, this update includes the TreatGx standard of providing personalized dosing based on any applicable pharmacogenetics, kidney function, liver function, and drug interactions. This update was...
All TreatGx users now have access to the updated treatment algorithm for Migraine Prophylaxis. This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. The algorithm now includes recommendations from...
All TreatGx users now have access to the updated treatment algorithm for Chronic Heart Failure. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. This update includes recommendations from the 2021 Update to...
General Update GenXys is one of the first groups to update our comprehensive precision prescribing algorithm to include the latest release from the Clinical Pharmacogenetics Implementation Consortium (CPIC) CYP2C19 Genotype and Clopidogrel Therapy, published January 19, 2022. We stay at the cutting-edge of research and are constantly...
All TreatGx users now have access to the updated treatment algorithm for ADHD. ADHD This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations from ADHD...
All TreatGx users now have access to the updated treatment algorithms for Post-Myocardial Infarction and Osteoporosis. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. Post-Myocardial Infarction This update includes recommendations from the 2013 ACCF/AHA Guidelines for...
All TreatGx users now have access to the updated treatment algorithm for Diabetes Mellitus Type 2. Diabetes Mellitus Type 2 This comprehensive update accounts for revisions made to existing clinical guidelines that will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations...
All TreatGx users now have access to the updated treatment algorithms for Hypertension and Migraine. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. General updates: a scope message has now been added...
We've got an exciting product release to share with you. This enterprise release of our software extends the capability, interoperability, security, and performance of the most robust and most performant pharmacogenetic (PGx) supported precision prescribing platform on the market. Falling into the wider category of...
We are pleased to announce an update to our Schizophrenia treatment algorithm. All TreatGx users now have access to the updated algorithm which includes many exciting enhancements that will help health care providers select the safest and most effective medications for their patients with schizophrenia. One...
